Abstract
The modulation of protein-protein interactions (PPIs) is a promising way for interrogating disease. Stapled peptides that stabilize peptides into a fixed α-helical conformation via chemical means are important representative compounds for regulating PPIs. The effect of the secondary conformation of peptides on the biophysical properties has not been explicitly elucidated due to the difficulty of obtaining peptide epimers with the same chemical composition but different conformations. Herein, we systematically designed and demonstrated the concept of “Chiral Center-Induced Helicity” (CIH) to stabilize the secondary structure of peptides. By introducing a precise R-configuration chiral center on the side-ring of a peptide, researchers can decisively regulate the secondary structure of peptides. Through the study of CIH peptides, we found that increasing the helicity can significantly enhance the stability of peptides and improve the cell membrane penetrating capability of the peptides. Moreover, the substitution group in the chiral center could contribute to additional interactions with the binding groove, which shows great significance for fragment-based drug design. This chapter will focus on the method involved in this research, including specific protocols of the synthesis and basic characterization of CIH peptides in Subheading 3.1. In addition, we have also extended the concept of CIH to dual-chiral center systems, including sulfoxide-based and sulfonium-based in-tether chiral center peptides, which we will introduce in Subheadings 3.2 and 3.3.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stelzl U, Worm U, Lalowski M et al (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122:957–968
Azzarito V, Long K, Murphy NS et al (2013) Inhibition of alpha-helix-mediated protein-protein interactions using designed molecules. Nat Chem 5:161–173
Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730
Verdine GL, Hilinski GJ (2012) Stapled peptides for intracellular drug targets. Methods Enzymol 503:3–33
Tsomaia N (2015) Peptide therapeutics: targeting the undruggable space. Eur J Med Chem 94:459–470
Craik DJ, Fairlie DP, Liras S (2013) The future of peptide-based drugs. Chem Biol Drug Des 81:136–147
Jochim AL, Arora PS (2010) Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. ACS Chem Biol 5:919–923
Marqusee S, Baldwin RL (1987) Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design. Proc Natl Acad Sci U S A 84:8898–8902
Felix AM, Heimer EP, Wang CT et al (1988) Synthesis, biological activity and conformational analysis of cyclic GRF analogs. Int J Pept Protein Res 32:441–454
Shepherd NE, Hoang HN, Abbenante G et al (2005) Single turn peptide alpha helices with exceptional stability in water. J Am Chem Soc 127:2974–2983
Osapay G, Taylor JW (1992) Multicyclic polypeptide model compounds. 2. Synthesis and conformational properties of a highly alpha-helical uncosapeptide constrained by 3 side-chain to side-chain lactam bridges. J Am Chem Soc 114:6966–6973
Phelan JC, Skelton NJ, Braisted AC et al (1997) A general method for constraining short peptides to an alpha-helical conformation. J Am Chem Soc 119:455–460
Yu CX, Taylor JW (1999) Synthesis and study of peptides with semirigid i and i+7 side-chain bridges designed for alpha-helix stabilization. Bioorg Med Chem 7:161–175
Fujimoto K, Kajino M, Inouye M (2008) Development of a series of cross-linking agents that effectively stabilize alpha-helical structures in various short peptides. Chemistry 14:857–863
Jackson DY, Schultz PG (1991) An antibody-catalyzed Cis trans isomerization reaction. J Am Chem Soc 113:2319–2321
Leduc AM, Trent JO, Wittliff JL et al (2003) Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions. Proc Natl Acad Sci U S A 100:11273–11278
Gutscher M, Pauleau AL, Marty L et al (2008) Real-time imaging of the intracellular glutathione redox potential. Nat Methods 5:553–559
Jo H, Meinhardt N, Wu Y et al (2012) Development of alpha-helical calpain probes by mimicking a natural protein-protein interaction. J Am Chem Soc 134:17704–17713
Muppidi A, Wang Z, Li X et al (2011) Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx. Chem Commun 47:9396–9398
Spokoyny AM, Zou YK, Ling JJ et al (2013) A Perfluoroaryl-cysteine SNAr chemistry approach to unprotected peptide stapling. J Am Chem Soc 135:5946–5949
Wang Y, Chou DH (2015) A thiol-ene coupling approach to native peptide stapling and macrocyclization. Angew Chem Int Ed Engl 54:10931–10934
Sletten EM, Bertozzi CR (2009) Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl 48:6974–6998
Kawamoto SA, Coleska A, Ran X et al (2012) Design of triazole-stapled BCL9 alpha-helical peptides to target the beta-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction. J Med Chem 55:1137–1146
Lau YH, de Andrade P, Quah ST et al (2014) Functionalised staple linkages for modulating the cellular activity of stapled peptides. Chem Sci 5:1804–1809
Chapman RN, Dimartino G, Arora PS (2004) A highly stable short alpha-helix constrained by a main-chain hydrogen-bond surrogate. J Am Chem Soc 126:12252–12253
Dimartino G, Wang DY, Chapman RN et al (2005) Solid-phase synthesis of hydrogen-bond surrogate-derived alpha-helices. Org Lett 7:2389–2392
Miller SE, Kallenbach NR, Arora PS (2012) Reversible alpha-helix formation controlled by a hydrogen bond surrogate. Tetrahedron 68:4434–4437
Mahon AB, Arora PS (2012) Design, synthesis and protein-targeting properties of thioether-linked hydrogen bond surrogate helices. Chem Commun 48:1416–1418
Henchey LK, Porter JR, Ghosh I et al (2010) High specificity in protein recognition by hydrogen-bond-surrogate alpha-helices: selective inhibition of the p53/MDM2 complex. Chembiochem 11:2104–2107
Wang D, Liao W, Arora PS (2005) Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. Angew Chem Int Ed Engl 44:6525–6529
Wang D, Lu M, Arora PS (2008) Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based alpha helices. Angew Chem Int Ed Engl 2008(47):1879–1882
Henchey LK, Kushal S, Dubey R et al (2010) Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix. J Am Chem Soc 132:941–943
Patgiri A, Yadav KK, Arora PS (2011) An orthosteric inhibitor of the Ras-Sos interaction. Nat Chem Biol 7:585–587
Schafmeister CE, Po J, Verdine GL (2000) An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides. J Am Chem Soc 2000(122):5891–5892
Kim YW, Kutchukian PS, Verdine GL (2010) Introduction of all-hydrocarbon i, i+3 staples into alpha-helices via ring-closing olefin metathesis. Org Lett 12:3046–3049
Kim YW, Verdine GL (2009) Stereochemical effects of all-hydrocarbon tethers in i, i+4 stapled peptides. Bioorg Med Chem Lett 19:2533–2536
Shim SY, Kim YW, Verdine GL (2013) A new i, i+3 peptide stapling system for alpha-helix stabilization. Chem Bio Drug Design 82:635–642
Hilinski GJ, Kim YW, Hong J et al (2014) Stitched alpha-helical peptides via Bis ring-closing metathesis. J Am Chem Soc 136:12314–12322
Hu K, Geng H, Zhang QZ et al (2016) An in-tether chiral center modulates the helicity, cell permeability, and target binding affinity of a peptide. Angew Chem Int Ed 55:8013–8017
Hu K, Li WJ, Yu MY et al (2016) Investigation of cellular uptakes of the in-tether chiral-center induced helical pentapeptides. Bioconjug Chem 27:2824–2847
Hu K, Sun CJ, Li ZG (2017) Reversible and versatile on-tether modification of chiral-center-induced helical peptides. Bioconjug Chem 28:2001–2007
Hu K, Sun CJ, Yang D et al (2017) A precisely positioned chiral center in an i, i+7 tether modulates the helicity of the backbone peptide. Chem Commun 53:6728–6731
Hu K, Sun CJ, Yu MY et al (2017) Dual in-tether chiral centers modulate peptide helicity. Bioconjug Chem 2017(28):1537–1543
Hu K, Yin F, Yu MY et al (2017) In-tether chiral center induced helical peptide modulators target p53-MDM2/MDMX and inhibit tumor growth in stem-like Cancer cell. Theranostics 7:4566–4576
Li JX, Hu K, Chen HL et al (2017) An in-tether chiral center modulates the proapoptotic activity of the KLA peptide. Chem Commun 53:10452–10455
Li WJ, Hu K, Zhang QZ et al (2018) N terminal N-methylation modulates chiral centre induced helical (CIH) peptides' biophysical properties. Chem Commun 54:1865–1868
Hu K, Jiang YX, Xiong W et al (2018) Tuning peptide self-assembly by an in-tether chiral center. Sci Adv 2018:4
Xiong W, Hu K, Li Z et al (2019) A wearable system based on core-shell structured peptide-Co9S8 supercapacitor and triboelectric nanogenerator. Nano Energy 2019:66
Hu K, Xiong W, Sun C et al (2020) Self-assembly of constrained cyclic peptides controlled by ring size. CCS Chem 2:42–51
Shi X, Liu Y, Zhao R et al (2018) Constructing thioether/vinyl sulfide-tethered helical peptides via photo-induced thiol-ene/yne hydrothiolation. J Vis Exp 138:e57356
Acknowledgments
We acknowledge financial support from the Natural Science Foundation of China grants 21778009, 21977010, 81701818, and 51803006; the Natural Science Foundation of Guangdong Province, 2020A1515010522; the Shenzhen Science and Technology Innovation Committee, JCYJ20180507181527112 and JCYJ201805081522131455. We acknowledge financial support from Beijing National Laboratory of Molecular Science open grant BNLMS20160112 and Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions grant 2019SHIBS0004. This work is supported by High-Performance Computing Platform of Peking University.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liu, Y., Hu, K., Yin, F., Li, Z. (2021). Facile Chemoselective Modification of Thioethers Generates Chiral Center-Induced Helical Peptides. In: Hussein, W.M., Stephenson, R.J., Toth, I. (eds) Peptide Conjugation. Methods in Molecular Biology, vol 2355. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1617-8_23
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1617-8_23
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1616-1
Online ISBN: 978-1-0716-1617-8
eBook Packages: Springer Protocols